CytoSorbents CFO Alexander D'Amico resigns weeks after appointment

Cytosorbents Corp

Alexander D'Amico resigned as CFO effective August 28, 2023 under mutual termination agreement.
D'Amico was appointed on July 10, 2023 (effective August 7, 2023) and served less than a month.
No severance payments or equity vesting; mutual non-disparagement and release provisions apply.
Kathleen Bloch continues as Interim CFO under existing consulting arrangement.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Alexander D'Amico

Chief Financial Officer

CTSO · Cytosorbents Corp

Effective: 2023-08-28
Filed: September 1, 2023, 7:59 PM ET

On August 28, 2023, the Company and Mr. D’Amico mutually agreed to terminate Mr. D’Amico’s employment with the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Alexander D'Amico resigned as Chief Financial Officer at Cytosorbents Corp.

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On August 28, 2023, the Company and Mr. D’Amico mutually agreed to terminate Mr. D’Amico’s employment with the Company.

View on SEC.gov

Cytosorbents Corp filing history →

Source: SEC EDGAR

accession 0001104659-23-097790

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.